Loading...

Monitoring Toxicity, Impact, and Adherence of Hydroxyurea in Children with Sickle Cell Disease

Hydroxyurea (HU) is underutilized in sickle cell disease (SCD). Patient adherence with taking HU and with required drug monitoring is a provider perceived barrier to HU utilization.(1-4) To determine process issues that may contribute to these barriers we sought to: 1) describe how providers monitor...

Full description

Saved in:
Bibliographic Details
Main Authors: Brandow, Amanda M., Panepinto, Julie A.
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804029/
https://ncbi.nlm.nih.gov/pubmed/21815183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.22101
Tags: Add Tag
No Tags, Be the first to tag this record!